دورية أكاديمية

A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin

التفاصيل البيبلوغرافية
العنوان: A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin
المؤلفون: Jain, AditiAff1, IDs13300023015043_cor1, Vispute, Abhay, Dange, Amol, Naskar, Arindam, Mondal, Asish, Vivekanand, B., Sharma, Balram, Varade, Deepak, Shukla, Dhaiwat, Bhatia, Girish, Chaudhari, Harshal, Ram Babu, K., Gavali, Onkar, Sorate, Sanket, Bhanushali, Shaishav, Kothari, Vaibhav, Khandelwal, Vipul, Sharma, Akhilesh, Pawar, Roshan, Mayabhate, Mayur, Shahavi, Vinayaka, Rajput, Aashishsingh, Jaiswal, Mukesh
المصدر: Diabetes Therapy: Research, treatment and education of diabetes and related disorders. 15(1):215-227
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:18696953
18696961
DOI:10.1007/s13300-023-01504-3